Guest views are now limited to 12 pages. If you get an "Error" message, just sign in! If you need to create an account, click here.

Jump to content
  • CRYPTO REWARDS!

    Full endorsement on this opportunity - but it's limited, so get in while you can!

Trump stops taking Corona drugs


Mary B
 Share

Recommended Posts

Trump stops taking Corona drugs

19:34 - 10/08/2020
 
  
%D8%AA%D8%B1%D8%A7%D9%85%D8%A8-%D9%83%D9

Information / follow-up.

US President Donald Trump said today, Thursday, that he has stopped taking most treatments for the emerging corona virus, but that he is still taking steroid stimulants.

Trump added in an interview: “It stopped, I no longer take it. “I think I have eaten almost nothing. I think I'm done with almost everything, ”but emphasized that he would continue taking the prescribed steroid for a little longer.

Trump, in a press briefing in front of the Oval Office of the White House, talks about treating Corona on Wednesday, October 7

He continued, “They have a steroid and not a heavy-duty steroid, and that will be a little longer. But I almost don't eat anything. ” The US President confirmed that he feels relieved after the treatment he received.

Last Thursday, Trump announced that he and the first lady, Melania Trump, had tested positive for the coronavirus. Trump was rushed to Walter Reed Medical Center for treatment the next day and discharged on Monday.

Yesterday, White House doctor Dr. Sean Connelly announced that the symptoms of the emerging corona virus disappeared from US President Donald Trump more than 24 hours ago.

Conley explained that the US president did not need "any additional oxygen and has not received any additional oxygen since his first admission to the hospital," noting at the same time that he was "fever-free for more than 4 days." 25 S.

https://www.almaalomah.com/2020/10/08/499032/

Link to comment
Share on other sites

New trials show the results of remdesivir on Corona patients ... Does it reduce deaths?

2020-10-09 | 04:39
New trials show the results of remdesivir on Corona patients ... Does it reduce deaths?
 
 
 
 
 

Remdesivir, which carried with it a glimmer of hope in the face of the emerging corona virus, has proven its ability to accelerate the recovery period only, and not to achieve a treatment that will reduce the number of deaths, according to the results of his final experiment.
 

A study of the company showed Gilead Sciences"The manufacturer of the drug, that the" Covid-19 "patients who took the drug recovered from the disease faster than others, after testing it on more than 1,000 patients from all over the world, according to what was published by the magazine.ForbesAmerican.
 
 
 
 
 

The experiments concluded that hospital patients who took "remdesivir" recovered from the disease in 10 days, that is, five days faster than those who took placebo medications, indicating that "the greatest benefit was in patients who were given the drug early with some additional oxygen." Remotely".

The data indicated that the remdesivir may prevent patients from developing severe symptoms and the need for more oxygen or ventilation, but did not find a decrease in the number of deaths for patients who took the drug.


For his part, CEO of the company, Daniel O'Day, considered that "for patients who are transferred to the hospital, recovery can be speeded up to 5 or 7 days."

The company is expected to use this result to apply for formal approval fromFood and Drug AdministrationAmerican drug, which has not been approved.

It is noteworthy that the clinical experience of this drug relied on giving a placebo last, as some patients take a drug that resembles remdesivir but does not carry any active substance inside it, in order to find out whether the patients recover with the help of the drug or if the psychological factor has a role in that.

This antiviral drug was developed to treat Ebola in the beginning, and it was issued in some African countries in 2015, but it failed to be a complete treatment and a complete cure.

https://www.alsumaria.tv/news/علم-وعالم/360908/تجارب-جديدة-تبيّن-نتائج-عقار-ريمديسيفير-على-مرضى-ك

Link to comment
Share on other sites

37 countries are competing to produce a vaccine for Covid 19 and the World Health Organization expects its production date

 17 minutes ago
 06 2 minutes
 
5ee71c09bdfc8.jpg

Yazidi 24 _ follow

Corona virus, no country has been excluded, regardless of the degrees of its scientific development, as it swooped on the world and paralyzed its movement in the absence of a vaccine or treatment. Hopes are placed on researchers and laboratories that have entered a feverish race, but the question is whether and when will you succeed in that ?, According to press sources, 37 countries around the world are competing to produce a vaccine for this virus.

When will the Corona vaccine be ready?

Scientists around the world use different means to produce many types of vaccine, according to Sky News, “Senior White House officials tried to disrupt these standards, because it would delay the launch of the vaccine, which is not in the service of President Donald Trump’s election campaign.”

The newspaper also stressed that "the new standards require that companies collect complete data about the safety of the vaccine during the final stage of clinical trials, before obtaining any permission for emergency use."

According to the "New York Times" newspaper, "The new and strict conditions make it difficult to have a vaccine against" Covid 19 "before the US presidential elections in November, because according to US President Donald Trump, these new criteria are tantamount to a conspiracy against his re-election, because it will lead to Delay in launching the vaccine.

Trump said in a tweet on "Twitter" that "these decisions constitute an obstacle to accelerating the development of the vaccine," as they constitute a "political blow," according to him.

The strongest optimists believe that “at least a year to a year and a half is necessary to develop a vaccine against the Corona pandemic,” as research laboratories and the pharmaceutical industry around the world seek to find vaccines and treatments for the emerging corona virus using a variety of different technologies.

And the Director of the World Health Organization, Tedros Adhanom, announced last Tuesday, October 6, 2020, that "the Corona virus vaccine may be ready by the end of this year."

The World Health Organization is currently working with scientists around the world to develop at least 20 different vaccines against the Corona virus, and some of them have already entered the phase of clinical trials in record time, but officials at the World Health Organization have warned that vaccines are still far from Make it available for public use.

Unlike the World Health Organization, Mexico says that "the Corona vaccine will be ready in the spring."

Al-Ain newspaper, its latest publications on the Corona vaccine confirmed, “Mexico has started an effort at the international level to establish diplomatic and commercial alliances to ensure access to 200 million vaccine doses that it deems it will need to confront the disease that has infected more than 263 thousand and killed at least 66851 in the country that represents the second The largest economy in Latin America, ”and it is clear that Mexico will participate in clinical trials of Russian and Italian vaccines.

European countries compete for the date of production of the Corona vaccine, and they are both (Britain and France)

According to Al Ain newspaper, "The French pharmaceutical company Sanofi and its British counterpart Glaxo Smithkline have started a clinical trial to test a protein vaccine for Covid-19 as part of the medical companies' efforts to develop pandemic treatments."

The two companies said, in a joint statement, on Thursday, that they have started the first phase of a two-stage test of the vaccine, which it hopes will roll out worldwide.

Al-Ain newspaper confirmed that "pharmaceutical companies and governments around the world are working to develop treatments for the Covid-19 pandemic, which killed more than 86 thousand and disrupted economic activity."

Sanofi and Glaxo said that they expect the first results of the vaccine by December 2020, and if the results are positive, they will plan to seek approval of the relevant authorities for the vaccine in the first half of 2021.″

According to what was published by the Iraqi Ministry of Health and Environment, “3923 cases infected with Coronavirus were recorded and 73 people died who were infected with the virus, confirming that 3413 people recovered from this virus in all regions of Iraq and the Kurdistan Region for one day.” With virus.

Iraq is seeking to reserve the Covid 19 vaccine for the highest possible percentage of its population because, according to informed sources, the virus has spread the highest in Iraq.

https://ezidi24.com/ar/?p=31879

Link to comment
Share on other sites

 

Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue

Apoorva Mandavilli and Nathalia Holt 10 hrs ago
 
 
 
 
 

Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue
 
 
 
 
 
 

When the Trump administration suspended federal funding in 2019 for most new scientific research projects involving fetal tissue derived from abortions, officials argued that whatever the scientific benefits, there was a pressing moral imperative to find alternative research methods.

© Juan Mabromata/Agence France-Presse — Getty Images A microscopic view of 293T cells derived from embryonic kidneys, which several companies are using to develop Covid-19 therapies.

“Promoting the dignity of human life from conception to natural death is one of the very top priorities of President Trump’s administration,” the Department of Health and Human Services said in a statement released at the time.

Yet the treatment for Covid-19 received by Mr. Trump — a cocktail of monoclonal antibodies he described as a “cure” in a celebratory video posted on Twitter — was developed using human cells derived from a fetus aborted decades ago.

Remdesivir, an antiviral drug that the president received late last week, was also developed with those cell lines. At least two companies racing to create a vaccine against the coronavirus, Moderna and AstraZeneca, are also relying on the cells. Johnson & Johnson is testing its vaccine in another so-called cell line originally produced from fetal tissue.

© Nicholas Kamm/Agence France-Presse — Getty Images In 2018, President Trump said that his administration would end a contract with the University of California, San Francisco, that involved research on fetal tissue.

As participants in the White House’s Operation Warp Speed, all three vaccine-makers have received federal funding.

A Trump administration official argued on Thursday that the president’s embracing of the treatments was not a contradiction. The administration’s policy on fetal tissue research “specifically excluded” cell lines made before June 2019, said the official, who did not wish to be identified because he was not authorized to speak about the matter.

Scientific products made using cell lines that existed before then “would not implicate the administration’s policy on the use of human fetal tissue from elective abortions,” the official said.

Some scientists saw a double standard in the president’s endorsement. “Hypocrisy has never bothered the man, as near as I can tell,” Lawrence Goldstein, a neuroscientist at the University of California, San Diego, who has used fetal tissue in his research, said of Mr. Trump.

Dr. Deepak Srivastava, a pediatric cardiologist who led the International Society for Stem Cell Research until July, said, “If they oppose this research, they should be willing to not take a drug that was developed using that.”

For decades, fetal tissue from abortions has been crucial to scientific research into treatments for conditions from birth defects to Ebola to cancer. And fetal tissue has been particularly important for studying the immune system, a key to designing treatments and vaccines for infectious diseases like Covid-19.

The cells used by most of the companies now trying to find a Covid-19 treatment, called the 293T line, were derived from the kidney tissue of a fetus aborted in the 1970s. A similar cell line, Per.C6, was obtained in 1985 from the retinal cells of an aborted 18-week-old fetus.

The treatment that Mr. Trump called a cure for Covid-19 is a cocktail of two monoclonal antibodies manufactured by Regeneron. Those antibodies are synthesized outside the body and then infused into patients to help fight off the infection.

Regeneron tested the antibodies against virus-like particles created using 293T human cells. The viral particles serve as a proxy for the live coronavirus; testing otherwise would require a lab with extremely high biosafety levels. (Eli Lilly, which also is manufacturing monoclonal antibodies, is using the same method.)

“293Ts were used in testing the antibodies’ ability to neutralize the virus,” said Alexandra Bowie, a spokeswoman for Regeneron. “They weren’t used in any other way, and fetal tissue was not used in the research.”

Mr. Trump’s resounding endorsement of Regeneron may run afoul of some religious groups and conservative leaders who have questioned the cells’ use to find treatments or vaccines for use against the coronavirus.

“One concern regarding the ethical assessment of viral vaccine candidates is the potential use of abortion-derived cell lines in the development, production or testing,” David Prentice, vice president of the Charlotte Lozier Institute, wrote in September.

His analysis identified 13 vaccine candidates for the coronavirus that rely on fetal cell lines.

Such research is “not morally responsible,” said Dr. James Sherley, a research scholar at the Charlotte Lozier Institute and director of the adult stem cell company Asymmetrex. “There are alternatives — there are lots of ways that don’t require the death of anyone.”

But other conservative leaders have sanctioned use of the cells, noting that they were developed decades ago, long before concerns about their fetal origins became a political issue.

In a letter sent to Mr. Trump in June, more than 100 members of Congress praised the president for his “efforts to protect the sanctity of all human life” but described 293T and Per.C6 as a “few old cell lines.”

On Thursday, some scientists dismissed that reasoning. “It’s not ethically sound to say, ‘Just because they’re made a long time ago, it’s OK if it’s going to save my life,’” Dr. Srivastava said.

Scientists argue that the administration’s position has prevented lifesaving research. Dr. Warner Greene, a researcher at the Gladstone Institutes, a nonprofit research organization in San Francisco, said, “The president’s decision regarding fetal tissue research has thwarted many, many promising lines of investigation.”

At the time of the ban, Dr. Greene was investigating a cure for H.I.V. with a collaborator at the Rocky Mountain Laboratories in Hamilton, Mont. The federal ban abruptly cut off their funding.

“Our experiments were stopped and halted in their tracks,” Dr. Greene said, adding that the work had not yet resumed.

As the administration sharply restricted fetal tissue research, it set up an ethics board to review scientific proposals at the National Institutes of Health. Grant renewals and new projects using fetal tissue are now considered by the Fetal Tissue Ethics Advisory Board, which met for the first time in July.

In August, the board rejected 13 of the 14 proposals it reviewed; the approved proposal relied on tissue that had already been acquired.

Some critics have suggested that scientists use tissue from spontaneous abortions rather than from elective ones. But spontaneous abortions often result from genetic and developmental abnormalities, rendering them unreliable for use in scientific research.

As an alternative to cells derived from fetal tissue, scientists may use mice engineered to carry human genes that may replicate parts of the immune system.

“There have been other modifications that some argue are almost as good, and they are helpful, but they are not the same as the truly humanized mouse from human fetal tissue,” Dr. Srivastava said.

In July, the stem cell society sent the new ethics board a letter, signed by 90 scientific, medical and patient organizations, that urged the board to allow fetal tissue to be used to develop treatments for Covid-19 and other diseases.

“Fetal tissue has unique and valuable properties that often cannot be replaced by other cell types,” the statement said.

The House Committee on Oversight and Reform found last month that the Trump administration’s ban on the use of federal funds for fetal tissue research was “based in ideological objections, not evaluation of the scientific merit of such projects.”

http://www.msn.com/en-us/health/medical/trumps-covid-treatments-were-tested-in-cells-derived-from-fetal-tissue/ar-BB19Qe28?li=BBnb7Kz&ocid=U453DHP

Link to comment
Share on other sites

An expert determines the necessary period to abandon the muzzle after vaccination against Corona

Editing date: 10/10/2020 9:50  21 times read
Where is news_ international

, Alexander Gintsberg, director of the "Gamalia" Center for Epidemiology and Microbiology, said that it is possible to abandon wearing a muzzle 21 days after vaccination with the second component of the vaccine against the Corona virus.

The expert added: "Then the level of antibodies must be determined for the person who received the vaccine."

The expert continued, "You must wait at least 21 days after vaccination with the vaccine, and I advise you to determine the level of antibodies, after that the person who received the vaccine has to decide for himself whether he should wear the mask or not. If the level of antibodies is high, then there is no need." To use the muzzle, and if the level is not sufficient, it is better to wear it. "

Last August, the Russian Ministry of Health registered the first vaccine in the world to prevent Covid-19 disease, which is the "Sputnik V" vaccine, which was developed by the "Gamalia" Center for Epidemiology and Microbiology, and was produced jointly with the Russian Direct Investment Fund.
Link to comment
Share on other sites

Experts reveal the time that the Corona virus lives on human skin

  •  Time: 10/10/2020 10:46:59
  •  
  •  Read: 2,262 times
Experts reveal the time that the Corona virus lives on human skin
  
{International: Al Furat News} Experts revealed that the emerging corona virus can live on human skin for a period of more than 4 times the time that the virus that causes influenza lives.

According to the newspaper "Life Science", the research was conducted using skin samples taken from people one day after their death.
The researchers from the College of Medicine at the University of "Kyoto Perfexual" Japanese said that human skin gives more accurate readings, because it suffers from "slower deterioration after death, compared to other organs."
The researchers noted that the virus lives on the skin for 9 hours, and with the presence of mucous materials on the skin, the Corona virus can live for 11 hours, according to the study.
The researchers claimed that the sterilizers that contain 80% alcohol kill the virus within 15 seconds, but the first option in combating the virus remains washing hands with soap and water for at least 20 seconds.
Ali al-Rubaie

https://alforatnews.com/news/خبراء-يكشفون-عن-الوقت-الذي-يعيشه-فيروس-كورونا-على-جلد-الإنسان

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
 Share

  • Recently Browsing   0 members

    • No registered users viewing this page.


  • Testing the Rocker Badge!

  • Live Exchange Rate

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.